Skip to main content
SpringerLink
Log in
Book cover

Stress and Skin Disorders pp 55–74Cite as

Itch and Stress

  • Chapter
  • First Online:

Abstract

Itch is one of the most common symptoms in dermatology, coexisting both with cutaneous disorders (e.g. atopic dermatitis, urticaria, psoriasis, eczema) and systemic disorders (e.g. renal, hepatic, endocrine or neurological). The occurrence of itch may be very bothersome and significantly reduces the health-related quality of life of an affected person. Pathogenesis of pruritus is not fully understood, although it is currently considered as a separate type of sensation. Stress is a complex term, having several definitions and numerous associations with physical, medical and psychological aspects of an individual’s life. Unsurprisingly, itch and stress are closely related to each other, emphasizing the crucial role of central nervous system in generating, sustaining and exacerbating of these symptoms. Stress may induce or exacerbate pre-existing itch while the presence of itch itself is associated with high levels of stress. A vicious itch-scratch-itch cycle appears in a person suffering from pruritus, leading to scratching, additional stress and further worsening of pruritus. The chapter covers main aspects of pathogenesis of pruritus and stress, reviews most common pruritic dermatoses and their relation with stress and describes current treatment modalities applied to alleviate pruritus and coexisting stress.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Rees WL. Stress, distress and disease. The Presidential Address at the annual meeting of the Royal College of Psychiatrists, held in London, 9th July, 1975. Br J Psychiatry. 1976;128:3–18.

    Article  CAS  PubMed  Google Scholar 

  2. Selye H. Stress without distress. In: Selye H, editor. Psychopathology of human adaptation. Boston: Springer; 1976. p. 137–46.

    Chapter  Google Scholar 

  3. Lazarus RS, Folkman S. Cognitive theories of stress and the issue of circularity. In: Appley MH, Trumbull RA, editors. Dynamics of stress. New York: Springer; 1988. p. 63–80.

    Google Scholar 

  4. Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, Zylicz Z. Itch: scratching more than the surface. QJM. 2003;96:7–26.

    Article  CAS  PubMed  Google Scholar 

  5. Steinhoff M, Bienenstock J, Schmelz M, Maurer M, Wei E, Bíró T. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol. 2006;126:1705–18.

    Article  CAS  PubMed  Google Scholar 

  6. Matterne U, Strassner T, Apfelbacher CJ, Diepgen TL, Weisshaar E. Measuring the prevalence of chronic itch in the general population: development and validation of a questionnaire for use in large-scale studies. Acta Derm Venereol. 2009;89:250–6.

    Article  PubMed  Google Scholar 

  7. Ständer S, Schäfer I, Phan NQ, Blome C, Herberger K, Heigel H, Augustin M. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology. 2010;221:229–35.

    Article  PubMed  Google Scholar 

  8. Weisshaar E, Szepietowski JC, Darsow U, Misery L, Wallengren J, Mettang T, Gieler U, Lotti T, Lambert J, Maisel P, Streit M, Greaves MW, Carmichael AJ, Tschachler E, Ring J, Ständer S. European guideline on chronic pruritus. Acta Derm Venereol. 2012;92:563–81.

    Article  PubMed  Google Scholar 

  9. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol. 2000;143:983–91.

    Article  CAS  PubMed  Google Scholar 

  10. Schneider G, Driesch G, Heuft G, Evers S, Luger TA, Ständer S. Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol. 2006;31:762–7.

    Article  CAS  PubMed  Google Scholar 

  11. Ständer S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, Bergasa NV, Gieler U, Misery L, Wallengren J, Darsow U, Streit M, Metze D, Luger TA, Greaves MW, Schmelz M, Yosipovitch G, Bernhard JD. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007;87:291–4.

    Article  PubMed  Google Scholar 

  12. Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, Marks R, Naldi L, Weinstock MA, Wulf SK, Michaud C, J L Murray C, Naghavi M. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134:1527–34.

    Article  CAS  PubMed  Google Scholar 

  13. Grand View Research. Pruritus therapeutics market by product (corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressant, calcineurin inhibitors, pipeline, unmet needs), by disease type is expected to reach USD 16.38 billion by 2025. Available at: http://www.grandviewresearch.com/press-release/global-pruritus-therapeutics-market. March 2015. Accessed 27 Jan 2016.

  14. Fortune DG, Main CJ, O’Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol. 1997;137:755–60.

    Article  CAS  PubMed  Google Scholar 

  15. Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006;4:35.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Finzi A, Colombo D, Caputo A, Andreassi L, Chimenti S, Vena G, Simoni L, Sgarbi S, Giannetti A, PSYCHAE Study Group. Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. J Eur Acad Dermatol Venereol. 2007;21:1161–9.

    Article  CAS  PubMed  Google Scholar 

  17. Niemeier V, Nippesen M, Kupfer J, Schill WB, Gieler U. Psychological factors associated with hand dermatoses: which subgroup needs additional psychological care? Br J Dermatol. 2002;146:1031–7.

    Article  CAS  PubMed  Google Scholar 

  18. Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B. Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol. 2004;18:27–36.

    Article  CAS  PubMed  Google Scholar 

  19. Verhoeven EW, Kraaimaat FW, de Jong EM, Schalkwijk J, van de Kerkhof PC, Evers AW. Individual differences in the effect of daily stressors on psoriasis: a prospective study. Br J Dermatol. 2009;161:295–9.

    Article  CAS  PubMed  Google Scholar 

  20. Balieva F, Lien L, Kupfer J, Halvorsen JA, Dalgard F. Are common skin diseases among Norwegian dermatological outpatients associated with psychological problems compared with controls? An observational study. Acta Derm Venereol. 2015;96(2):227–31. doi:10.2340/00015555-2200.

    Article  Google Scholar 

  21. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF. Cellular basis of itch sensation. Science. 2009;325:1531–4.

    Article  CAS  PubMed  Google Scholar 

  22. Paus R, Schmelz M, Bíró T, Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest. 2006;116:1174–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Handwerker HO, Forster C, Kirchhoff C. Discharge patterns of human C-fibers induced by itching and burning stimuli. J Neurophysiol. 1991;66:307–15.

    CAS  PubMed  Google Scholar 

  24. Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci. 2001;4:72–7.

    Article  CAS  PubMed  Google Scholar 

  25. Ringkamp M, Schepers RJ, Shimada SG, Johanek LM, Hartke TV, Borzan J, Shim B, LaMotte RH, Meyer RA. A role for nociceptive, myelinated nerve fibers in itch sensation. J Neurosci. 2011;31:14841–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Darsow U, Drzezga A, Frisch M, Munz F, Weilke F, Bartenstein P, Schwaiger M, Ring J. Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. J Invest Dermatol. 2000;115:1029–33.

    Article  CAS  PubMed  Google Scholar 

  27. Drzezga A, Darsow U, Treede RD, Siebner H, Frisch M, Munz F, Weilke F, Ring J, Schwaiger M, Bartenstein P. Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain. 2001;92:295–305.

    Article  CAS  PubMed  Google Scholar 

  28. Mochizuki H, Sadato N, Saito DN, Toyoda H, Tashiro M, Okamura N, Yanai K. Neural correlates of perceptual difference between itching and pain: a human fMRI study. Neuroimage. 2007;36:706–17.

    Article  PubMed  Google Scholar 

  29. Misery L. Atopic dermatitis and the nervous system. Clin Rev Allergy Immunol. 2011;41:259–66.

    Article  CAS  PubMed  Google Scholar 

  30. Papoiu AD, Coghill RC, Kraft RA, Wang H, Yosipovitch G. A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch. Neuroimage. 2012;59:3611–23.

    Article  PubMed  Google Scholar 

  31. Heyer G, Vogelgsang M, Hornstein OP. Acetylcholine is an inducer of itching in patients with atopic eczema. J Dermatol. 1997;24:621–5.

    Article  CAS  PubMed  Google Scholar 

  32. Heyer G, Groene D, Martus P. Efficacy of naltrexone on acetylcholine-induced alloknesis in atopic eczema. Exp Dermatol. 2002;11:448–55.

    Article  CAS  PubMed  Google Scholar 

  33. Shimizu K, Andoh T, Yoshihisa Y, Shimizu T. Histamine released from epidermal keratinocytes plays a role in α-melanocyte-stimulating hormone-induced itching in mice. Am J Pathol. 2015;185:3003–10.

    Article  CAS  PubMed  Google Scholar 

  34. Lee CH, Hong CH, Yu WT, Chuang HY, Huang SK, Chen GS, Yoshioka T, Sakata M, Liao WT, Ko YC, Yu HS. Mechanistic correlations between two itch biomarkers, cytokine interleukin-31 and neuropeptide β-endorphin, via STAT3/calcium axis in atopic dermatitis. Br J Dermatol. 2012;167:794–803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Haustein UF. Adrenergic urticaria and adrenergic pruritus. Acta Derm Venereol. 1990;70:82–4.

    CAS  PubMed  Google Scholar 

  36. Hundley JL, Yosipovitch G. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study. J Am Acad Dermatol. 2004;50:889–91.

    Article  PubMed  Google Scholar 

  37. Tobin D, Nabarro G, Baart de la Faille H, van Vloten WA, van der Putte SC, Schuurman HJ. Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol. 1992;90:613–22.

    Article  CAS  PubMed  Google Scholar 

  38. McCoy ES, Taylor-Blake B, Zylka MJ. CGRPα-expressing sensory neurons respond to stimuli that evoke sensations of pain and itch. PLoS One. 2012;7:e36355. doi:10.1371/journal.pone.0036355.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Rogoz K, Andersen HH, Lagerström MC, Kullander K. Multimodal use of calcitonin gene-related peptide and substance P in itch and acute pain uncovered by the elimination of vesicular glutamate transporter 2 from transient receptor potential cation channel subfamily V member 1 neurons. J Neurosci. 2014;34:14055–68.

    Article  PubMed  CAS  Google Scholar 

  40. Gomes LO, Hara DB, Rae GA. En dothelin-1 induces itch and pain in the mouse cheek model. Life Sci. 2012;91:628–33.

    Article  CAS  PubMed  Google Scholar 

  41. Kido-Nakahara M, Buddenkotte J, Kempkes C, Ikoma A, Cevikbas F, Akiyama T, Nunes F, Seeliger S, Hasdemir B, Mess C, Buhl T, Sulk M, Müller FU, Metze D, Bunnett NW, Bhargava A, Carstens E, Furue M, Steinhoff M. Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1-induced pruritus. J Clin Invest. 2014;124:2683–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature. 2007;448:700–3.

    Article  CAS  PubMed  Google Scholar 

  43. Andoh T, Kuwazono T, Lee JB, Kuraishi Y. Gastrin-releasing peptide induces itch-related responses through mast cell degranulation in mice. Peptides. 2011;32:2098–103.

    Article  CAS  PubMed  Google Scholar 

  44. Nattkemper LA, Zhao ZQ, Nichols AJ, Papoiu AD, Shively CA, Chen ZF, Yosipovitch G. Overexpression of the gastrin-releasing peptide in cutaneous nerve fibers and its receptor in the spinal cord in primates with chronic itch. J Invest Dermatol. 2013;133:2489–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;117:411–7.

    Article  CAS  PubMed  Google Scholar 

  46. Raap U, Wichmann K, Bruder M, Ständer S, Wedi B, Kapp A, Werfel T. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol. 2008;122:421–3.

    Article  CAS  PubMed  Google Scholar 

  47. Tanaka A, Matsuda H. Expression of nerve growth factor in itchy skins of atopic NC/NgaTnd mice. J Vet Med Sci. 2005;67:915–9.

    Article  CAS  PubMed  Google Scholar 

  48. Suga H, Sugaya M, Miyagaki T, Ohmatsu H, Fujita H, Kagami S, Asano Y, Tada Y, Kadono T, Sato S. Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma. Acta Derm Venereol. 2013;93:144–9.

    Article  CAS  PubMed  Google Scholar 

  49. Akiyama T, Nguyen T, Curtis E, Nishida K, Devireddy J, Delahanty J, Carstens MI, Carstens E. A central role for spinal dorsal horn neurons that express neurokinin-1 receptors in chronic itch. Pain. 2015;156:1240–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Ko MC, Song MS, Edwards T, Lee H, Naughton NN. The role of central mu opioid receptors in opioid-induced itch in primates. J Pharmacol Exp Ther. 2004;310:169–76.

    Article  CAS  PubMed  Google Scholar 

  51. Phan NQ, Lotts T, Antal A, Bernhard JD, Ständer S. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. Acta Derm Venereol. 2012;92(5):555–60.

    Article  PubMed  Google Scholar 

  52. Jannuzzi RG. Nalbuphine for treatment of opioidinduced pruritus: a systematic review of literature. Clin J Pain. 2016;32:87–93.

    Article  PubMed  Google Scholar 

  53. Neisius U, Olsson R, Rukwied R, Lischetzki G, Schmelz M. Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J Am Acad Dermatol. 2002;47:28–32.

    Article  PubMed  Google Scholar 

  54. Yosipovitch G. The pruritus receptor unit: a target for novel therapies. J Invest Dermatol. 2007;127:1857–9.

    Article  CAS  PubMed  Google Scholar 

  55. Reddy VB, Lerner EA. Plant cysteine proteases that evoke itch activate protease-activated receptors. Br J Dermatol. 2010;163:532–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Akiyama T, Lerner EA, Carstens E. Protease-activated receptors and itch. Handb Exp Pharmacol. 2015;226:219–35.

    Article  CAS  PubMed  Google Scholar 

  57. Ostlere LS, Cowen T, Rustin MH. Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol. 1995;20:462–7.

    Article  CAS  PubMed  Google Scholar 

  58. Ständer S, Luger TA. Itch in atopic dermatitis – pathophysiology and treatment. Acta Dermatovenerol Croat. 2010;18:289–96.

    PubMed  Google Scholar 

  59. Rukwied R, Heyer G. Cutaneous reactions and sensations after intracutaneous injection of vasoactive intestinal polypeptide and acetylcholine in atopic eczema patients and healthy controls. Arch Dermatol Res. 1998;290:198–204.

    Article  CAS  PubMed  Google Scholar 

  60. Rukwied R, Heyer G. Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients. Exp Dermatol. 1999;8:39–45.

    Article  CAS  PubMed  Google Scholar 

  61. Reich A, Ständer S, Szepietowski JC. Drug-induced pruritus: a review. Acta Derm Venereol. 2009;89:236–44.

    Article  PubMed  Google Scholar 

  62. Zylicz Z, Smits C, Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage. 1998;16:121–4.

    Article  CAS  PubMed  Google Scholar 

  63. Biondi M, Arcangeli T, Petrucci RM. Paroxetine in a case of psychogenic pruritus and neurotic excoriations. Psychother Psychosom. 2000;69:165–6.

    Article  CAS  PubMed  Google Scholar 

  64. Tefferi A, Fonseca R. Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus. Blood. 2002;99:2627.

    Article  CAS  PubMed  Google Scholar 

  65. Browning J, Combes B, Mayo MJ. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol. 2003;98:2736–41.

    Article  CAS  PubMed  Google Scholar 

  66. Cederberg J, Knight S, Svenson S, Melhus H. Itch and skin rash from chocolate during fluoxetine and sertraline treatment: case report. BMC Psychiatry. 2004;4:36.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Mazzatenta C, Peonia G, Martini P. Pruritus induced by interruption of paroxetine therapy. Br J Dermatol. 2004;150:787–8.

    Article  CAS  PubMed  Google Scholar 

  68. Papoiu AD, Wang H, Coghill RC, Chan YH, Yosipovitch G. Contagious itch in humans: a study of visual ‘transmission’ of itch in atopic dermatitis and healthy subjects. Br J Dermatol. 2011;164:1299–303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. van Laarhoven AI, Vogelaar ML, Wilder-Smith OH, van Riel PL, van de Kerkhof PC, Kraaimaat FW, Evers AW. Induction of nocebo and placebo effects on itch and pain by verbal suggestions. Pain. 2011;152:1486–94.

    Article  PubMed  Google Scholar 

  70. Bartels DJ, van Laarhoven AI, Haverkamp EA, Wilder-Smith OH, Donders AR, van Middendorp H, van de Kerkhof PC, Evers AW. Role of conditioning and verbal suggestion in placebo and nocebo effects on itch. PLoS One. 2014;9:e91727. doi:10.1371/journal.pone.0091727.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  71. Holle H, Warne K, Seth AK, Critchley HD, Ward J. Neural basis of contagious itch and why some people are more prone to it. Proc Natl Acad Sci U S A. 2012;109:19816–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Dalgard F, Stern R, Lien L, Hauser S. Itch, stress and self-efficacy among 18-year-old boys and girls: a Norwegian population-based cross-sectional study. Acta Derm Venereol. 2012;92:547–52.

    Article  PubMed  Google Scholar 

  73. Bandura A. Self-efficacy. In: Ramachaudran VS, editor. Encyclopedia of human behaviour, vol. 4. New York: Academic Press; 1994. p. 71–81.

    Google Scholar 

  74. Ward L, Wright E, McMahon SB. A comparison of the effects of noxious and innocuous counterstimuli on experimentally induced itch and pain. Pain. 1996;64:129–38.

    Article  CAS  PubMed  Google Scholar 

  75. Yosipovitch G, Duque MI, Fast K, Dawn AG, Coghill RC. Scratching and noxious heat stimuli inhibit itch in humans: a psychophysical study. Br J Dermatol. 2007;156:629–34.

    Article  CAS  PubMed  Google Scholar 

  76. Akiyama T, Iodi Carstens M, Carstens E. Transmitters and pathways mediating inhibition of spinal itch-signaling neurons by scratching and other counterstimuli. PLoS One. 2011;6:e22665. doi:10.1371/journal.pone.0022665.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Kardon AP, Polgár E, Hachisuka J, Snyder LM, Cameron D, Savage S, Cai X, Karnup S, Fan CR, Hemenway GM, Bernard CS, Schwartz ES, Nagase H, Schwarzer C, Watanabe M, Furuta T, Kaneko T, Koerber HR, Todd AJ, Ross SE. Dynorphin acts as a neuromodulator to inhibit itch in the dorsal horn of the spinal cord. Neuron. 2014;82:573–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Liu Y, Abdel Samad O, Zhang L, Duan B, Tong Q, Lopes C, Ji RR, Lowell BB, Ma Q. VGLUT2-dependent glutamate release from nociceptors is required to sense pain and suppress itch. Neuron. 2010;68:543–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Lagerström MC, Rogoz K, Abrahamsen B, Persson E, Reinius B, Nordenankar K, Olund C, Smith C, Mendez JA, Chen ZF, Wood JN, Wallén-Mackenzie A, Kullander K. VGLUT2-dependent sensory neurons in the TRPV1 population regulate pain and itch. Neuron. 2010;68:529–42.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  80. Roblin D, Yosipovitch G, Boyce B, Robinson J, Sandy J, Mainero V, Wickramasinghe R, Anand U, Anand P. Topical TrkA kinase inhibitor CT327 is an effective, novel therapy for the treatment of pruritus due to psoriasis: results from experimental studies, and efficacy and safety of CT327 in a phase 2b clinical trial in patients with psoriasis. Acta Derm Venereol. 2015;95:542–8.

    Article  CAS  PubMed  Google Scholar 

  81. Grandgeorge M, Misery L. Mediators of the relationship between stress and itch. Exp Dermatol. 2015;24:334–5.

    Article  PubMed  Google Scholar 

  82. Arck P, Paus R. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation. 2006;13:347–56.

    Article  CAS  PubMed  Google Scholar 

  83. Kim HS, Yosipovitch G. An aberrant parasympathetic response: a new perspective linking chronic stress and itch. Exp Dermatol. 2013;22:239–44.

    Article  PubMed  Google Scholar 

  84. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66:8–16.

    Article  CAS  PubMed  Google Scholar 

  85. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980;92(Suppl):44–7.

    Google Scholar 

  86. Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, Bingham EA, Finlay AY, Pembroke AC, Graham-Brown RA. The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol. 1994;131:383–96.

    Article  CAS  PubMed  Google Scholar 

  87. Hanifin JM. Pharmacophysiology of atopic dermatitis. Clin Rev Allergy. 1986;4:43–65.

    CAS  PubMed  Google Scholar 

  88. Morren MA, Przybilla B, Bamelis M, Heykants B, Reynaers A, Degreef H. Atopic dermatitis: triggering factors. J Am Acad Dermatol. 1994;31:467–73.

    Article  CAS  PubMed  Google Scholar 

  89. Lee CH, Chuang HY, Shih CC, Jong SB, Chang CH, Yu HS. Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis. Br J Dermatol. 2006;154:1100–7.

    Article  CAS  PubMed  Google Scholar 

  90. Polańska A, Dańczak-Pazdrowska A, Silny W, Jenerowicz D, Osmola-Mańkowska A, Olek-Hrab K. Evaluation of selected skin barrier functions in atopic dermatitis in relation to the disease severity and pruritus. Postep Derm Alergol. 2012;29:373–7.

    Article  Google Scholar 

  91. Tominaga M, Takamori K. Itch and nerve fibers with special reference to atopic dermatitis: therapeutic implications. J Dermatol. 2014;41:205–12.

    Article  CAS  PubMed  Google Scholar 

  92. Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D. Increased concentration of beta-endorphin in the sera of patients with severe atopic dermatitis. Acta Derm Venereol. 1995;75:9–11.

    CAS  PubMed  Google Scholar 

  93. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol. 2002;147:71–9.

    Article  CAS  PubMed  Google Scholar 

  94. Hon KL, Lam MC, Wong KY, Leung TF, Ng PC. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P. Br J Dermatol. 2007;157:922–5.

    Article  CAS  PubMed  Google Scholar 

  95. Salomon J, Baran E. The role of selected neuropeptides in pathogenesis of atopic dermatitis. J Eur Acad Dermatol Venereol. 2008;22:223–8.

    CAS  PubMed  Google Scholar 

  96. Teresiak-Mikołajczak E, Czarnecka-Operacz M, Jenerowicz D, Silny W. Neurogenic markers of the inflammatory process in atopic dermatitis: relation to the severity and pruritus. Postepy Dermatol Alergol. 2013;30:286–92.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Imaizumi A, Kawakami T, Murakami F, Soma Y, Mizoguchi M. Effective treatment of pruritus in atopic dermatitis using H1 antihistamines (second-generation antihistamines): changes in blood histamine and tryptase levels. J Dermatol Sci. 2003;33:23–9.

    Article  CAS  PubMed  Google Scholar 

  98. Rukwied R, Lischetzki G, McGlone F, Heyer G, Schmelz M. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br J Dermatol. 2000;142:1114–20.

    Article  CAS  PubMed  Google Scholar 

  99. Lippert U, Hoer A, Möller A, Ramboer I, Cremer B, Henz BM. Role of antigen-induced cytokine release in atopic pruritus. Int Arch Allergy Immunol. 1998;116:36–9.

    Article  CAS  PubMed  Google Scholar 

  100. Takaoka A, Arai I, Sugimoto M, Honma Y, Futaki N, Nakamura A, Nakaike S. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Exp Dermatol. 2006;15:161–7.

    Article  CAS  PubMed  Google Scholar 

  101. Oh MH, Oh SY, Lu J, Lou H, Myers AC, Zhu Z, Zheng T. TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis. J Immunol. 2013;191:5371–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Yosipovitch G, Goon AT, Wee J, Chan YH, Zucker I, Goh CL. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol. 2002;41:212–6.

    Article  PubMed  Google Scholar 

  103. Dawn A, Papoiu AD, Chan YH, Rapp SR, Rassette N, Yosipovitch G. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol. 2009;160:642–4.

    Article  CAS  PubMed  Google Scholar 

  104. Oh SH, Bae BG, Park CO, Noh JY, Park IH, Wu WH, Lee KH. Association of stress with symptoms of atopic dermatitis. Acta Derm Venereol. 2010;90:582–8.

    Article  PubMed  Google Scholar 

  105. Chrostowska-Plak D, Reich A, Szepietowski JC. Relationship between itch and psychological status of patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2013;27:e239–42.

    Article  CAS  PubMed  Google Scholar 

  106. Peters EM, Michenko A, Kupfer J, Kummer W, Wiegand S, Niemeier V, Potekaev N, Lvov A, Gieler U. Mental stress in atopic dermatitis – neuronal plasticity and the cholinergic system are affected in atopic dermatitis and in response to acute experimental mental stress in a randomized controlled pilot study. PLoS One. 2012;9:e113552. doi:10.1371/journal.pone.0113552.

    Article  CAS  Google Scholar 

  107. Tran BW, Papoiu AD, Russoniello CV, Wang H, Patel TS, Chan YH, Yosipovitch G. Effect of itch, scratching and mental stress on autonomic nervous system function in atopic dermatitis. Acta Derm Venereol. 2010;90:354–61.

    Article  PubMed  Google Scholar 

  108. Schut C, Bosbach S, Gieler U, Kupfer J. Personality traits, depression and itch in patients with atopic dermatitis in an experimental setting: a regression analysis. Acta Derm Venereol. 2014;94:20–5.

    Article  PubMed  Google Scholar 

  109. Schut C, Weik U, Tews N, Gieler U, Deinzer R, Kupfer J. Coping as mediator of the relationship between stress and itch in patients with atopic dermatitis: a regression and mediation analysis. Exp Dermatol. 2015;24:148–50.

    Article  CAS  PubMed  Google Scholar 

  110. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377–85.

    Article  CAS  PubMed  Google Scholar 

  111. Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70:512–6.

    Article  PubMed  Google Scholar 

  112. Gupta MA, Gupta AK, Kirkby S, Weiner HK, Mace TM, Schork NJ, Johnson EH, Ellis CN, Voorhees JJ. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol. 1988;124(7):1052–7.

    Article  CAS  PubMed  Google Scholar 

  113. Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969–73.

    Article  CAS  PubMed  Google Scholar 

  114. Szepietowski JC, Reich A, Wiśnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat. 2002;10:221–6.

    PubMed  Google Scholar 

  115. Reich A, Szepietowski JC, Wiśnicka B, Pacan P. Does stress influence itching in psoriatic patients? Dermatol Psychosom. 2003;4:151–5.

    Article  Google Scholar 

  116. Chang SE, Han SS, Jung HJ, Choi JH. Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol. 2007;156:1272–7.

    Article  PubMed  Google Scholar 

  117. Reich A, Hrehorów E, Szepietowski JC. Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol. 2010;90:257–63.

    Article  PubMed  Google Scholar 

  118. Amatya B, Wennersten G, Nordlind K. Patients’ perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study. J Eur Acad Dermatol Venereol. 2008;22:822–6.

    Article  CAS  PubMed  Google Scholar 

  119. Prignano F, Ricceri F, Pescitelli L, Lotti T. Itch in psoriasis: epidemiology, clinical aspects and treatment options. Clin Cosmet Investig Dermatol. 2009;2:9–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Bilac C, Ermertcan AT, Bilac DB, Deveci A, Horasan GD. The relationship between symptoms and patient characteristics among psoriasis patients. Indian J Dermatol Venereol Leprol. 2009;75:551.

    PubMed  Google Scholar 

  121. Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol. 2003;149:718–30.

    Article  CAS  PubMed  Google Scholar 

  122. Madej A, Reich A, Orda A, Szepietowski JC. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients. J Eur Acad Dermatol Venereol. 2007;21:72–8.

    Article  CAS  PubMed  Google Scholar 

  123. Wiśnicka B, Szepietowski JC, Reich A, Orda A. Histamine, substance P and calcitonin gene-related peptide plasma concentration and pruritus in patients suffering from psoriasis. Dermatol Psychosom. 2004;5:73–8.

    Article  Google Scholar 

  124. Reich A, Orda A, Wiśnicka B, Szepietowski JC. Plasma concentration of selected neuropeptides in patients suffering from psoriasis. Exp Dermatol. 2007;16:421–8.

    Article  CAS  PubMed  Google Scholar 

  125. Taneda K, Tominaga M, Negi O, Tengara S, Kamo A, Ogawa H, Takamori K. Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch. Br J Dermatol. 2011;165:277–84.

    Article  PubMed  Google Scholar 

  126. Kou K, Nakamura F, Aihara M, Chen H, Seto K, Komori-Yamaguchi J, Kambara T, Nagashima Y, Goshima Y, Ikezawa Z. Decreased expression of semaphorin-3A, a neurite-collapsing factor, is associated with itch in psoriatic skin. Acta Derm Venereol. 2012;92:521–8.

    Article  CAS  PubMed  Google Scholar 

  127. Nigam R, El-Nour H, Amatya B, Nordlind K. GABA and GABA(A) receptor expression on immune cells in psoriasis: a pathophysiological role. Arch Dermatol Res. 2010;302:507–15.

    Article  CAS  PubMed  Google Scholar 

  128. Reich A, Welz-Kubiak K, Rams L. Apprehension of the disease by patients suffering from psoriasis. Postepy Dermatol Alergol. 2014;31:289–93.

    Article  PubMed  PubMed Central  Google Scholar 

  129. Lebwohl MG, Bachelez H, Barker J, Girolomoni G, Kavanaugh A, Langley RG, Paul CF, Puig L, Reich K, van de Kerkhof PC. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol. 2014;70:871–81.

    Article  PubMed  Google Scholar 

  130. Remröd C, Lonne-Rahm S, Nordlind K. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch Dermatol Res. 2007;299:85–91.

    Article  PubMed  CAS  Google Scholar 

  131. Gupta MA, Gupta AK. Stressful major life events are associated with a higher frequency of cutaneous sensory symptoms: an empirical study of non-clinical subjects. J Eur Acad Dermatol Venereol. 2004;18:560–5.

    Article  CAS  PubMed  Google Scholar 

  132. Sánchez-Borges M, Asero R, Ansotegui IJ, Baiardini I, Bernstein JA, Canonica GW, Gower R, Kahn DA, Kaplan AP, Katelaris C, Maurer M, Park HS, Potter P, Saini S, Tassinari P, Tedeschi A, Ye YM, Zuberbier T. Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J. 2012;5:125–47.

    Article  PubMed  PubMed Central  Google Scholar 

  133. Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol. 2010;35:869–73.

    Article  CAS  PubMed  Google Scholar 

  134. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med. 2002;346:175–9.

    Article  PubMed  Google Scholar 

  135. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M. The EAACI/GA(2) LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014;69:868–87.

    Article  CAS  PubMed  Google Scholar 

  136. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105:664–72.

    Article  CAS  PubMed  Google Scholar 

  137. O’Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136:197–201.

    Article  PubMed  Google Scholar 

  138. Baiardini I, Giardini A, Pasquali M, Dignetti P, Guerra L, Specchia C, Braido F, Majani G, Canonica GW. Quality of life and patients’ satisfaction in chronic urticaria and respiratory allergy. Allergy. 2003;58:621–3.

    Article  CAS  PubMed  Google Scholar 

  139. Grob JJ, Revuz J, Ortonne JP, Auquier P, Lorette G. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol. 2005;152:289–95.

    Article  CAS  PubMed  Google Scholar 

  140. Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol. 1999;140:667–71.

    Article  CAS  PubMed  Google Scholar 

  141. Maurer M, Ortonne JP, Zuberbier T. Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy. 2009;64:581–8.

    Article  CAS  PubMed  Google Scholar 

  142. Conrad R, Geiser F, Haidl G, Hutmacher M, Liedtke R, Wermter F. Relationship between anger and pruritus perception in patients with chronic idiopathic urticaria and psoriasis. J Eur Acad Dermatol Venereol. 2008;22:1062–9.

    Article  CAS  PubMed  Google Scholar 

  143. Reich A, Trybucka K, Tracinska A, Samotij D, Jasiuk B, Srama M, Szepietowski JC. Acne itch: do acne patients suffer from itching? Acta Derm Venereol. 2008;88:38–42.

    Article  PubMed  Google Scholar 

  144. Lim YL, Chan YH, Yosipovitch G, Greaves MW. Pruritus is a common and significant symptom of acne. J Eur Acad Dermatol Venereol. 2008;22:1332–6.

    Article  CAS  PubMed  Google Scholar 

  145. Peyrí J, Lleonart M. Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis. Actas Dermosifiliogr. 2007;98:476–82 [article in Spanish].

    Article  PubMed  Google Scholar 

  146. Kiecolt-Glaser JK, Marucha PT, Malarkey WB, Mercado AM, Glaser R. Slowing of wound healing by psychological stress. Lancet. 1995;346:1194–6.

    Article  CAS  PubMed  Google Scholar 

  147. Cole-King A, Harding KG. Psychological factors and delayed healing in chronic wounds. Psychosom Med. 2001;63:216–20.

    Article  CAS  PubMed  Google Scholar 

  148. Gouin JP, Kiecolt-Glaser JK. The impact of psychological stress on wound healing: methods and mechanisms. Immunol Allergy Clin North Am. 2011;31:81–93.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Van Loey NE, Bremer M, Faber AW, Middelkoop E, Nieuwenhuis MK. Itching following burns: epidemiology and predictors. Br J Dermatol. 2008;158:95–100.

    PubMed  Google Scholar 

  150. Misery L, Alexandre S, Dutray S, Chastaing M, Consoli SG, Audra H, Bauer D, Bertolus S, Callot V, Cardinaud F, Corrin E, Feton-Danou N, Malet R, Touboul S, Consoli SM. Functional itch disorder or psychogenic pruritus: suggested diagnosis criteria from the French psychodermatology group. Acta Derm Venereol. 2007;87:341–4.

    Article  PubMed  Google Scholar 

  151. Stangier U, Köhnlein B, Gieler U. Somatoforme Störungen bei ambulanten dermatologischen Patienten. Psychotherapeut. 2003;48:321–8 [article in German].

    Article  Google Scholar 

  152. Kretzmer GE, Gelkopf M, Kretzmer G, Melamed Y. Idiopathic pruritus in psychiatric inpatients: an explorative study. Gen Hosp Psychiatry. 2008;30:344–8.

    Article  PubMed  Google Scholar 

  153. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, Schäfer T, Schwennesen T, Seidenari S, Simon D, Ständer S, Stingl G, Szalai S, Szepietowski JC, Taïeb A, Werfel T, Wollenberg A, Darsow U. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26:1045–60.

    Article  CAS  PubMed  Google Scholar 

  154. Simons FE, Simons KJ. H1 antihistamines: current status and future directions. World Allergy Organ J. 2008;1:145–55.

    Article  PubMed  PubMed Central  Google Scholar 

  155. Beck LA, Thaçi D, Hamilton JD, Graham NM, Bieber T, Rocklin R, Ming JE, Ren H, Kao R, Simpson E, Ardeleanu M, Weinstein SP, Pirozzi G, Guttman-Yassky E, Suárez-Fariñas M, Hager MD, Stahl N, Yancopoulos GD, Radin AR. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371:130–9.

    Article  PubMed  CAS  Google Scholar 

  156. Paul C, Cather J, Gooderham M, Poulin Y, Mrowietz U, Ferrandiz C, Crowley J, Hu C, Stevens RM, Shah K, Day RM, Girolomoni G, Gottlieb AB. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2). Br J Dermatol. 2015;173:1387–99.

    Article  CAS  PubMed  Google Scholar 

  157. Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage. 2003;26:1105–12.

    Article  CAS  PubMed  Google Scholar 

  158. Mayo MJ, Handem I, Saldana S, Jacobe H, Getachew Y, Rush AJ. Sertraline as a first-line treatment for cholestatic pruritus. Hepatology. 2007;45:666–74.

    Article  CAS  PubMed  Google Scholar 

  159. Shakiba M, Sanadgol H, Azmoude HR, et al. Effect of sertraline on uremic pruritus improvement in ESRD patients. Int J Nephrol. 2012;2012:363901.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  160. Chan KY, Li CW, Wong H, Yip T, Chan ML, Cheng HW, Sham MK. Use of sertraline for antihistamine-refractory uremic pruritus in renal palliative care patients. J Palliat Med. 2013;16:966–70.

    Article  PubMed  Google Scholar 

  161. van Os-Medendorp H, Ros WJ, Eland-de Kok PC, Kennedy C, Thio BH, van der Schuur-van der Zande A, Grypdonck MH, Bruijnzeel-Koomen CA. Effectiveness of the nursing programme ‘Coping with itch’: a randomized controlled study in adults with chronic pruritic skin disease. Br J Dermatol. 2007;156:1235–44.

    Article  PubMed  Google Scholar 

  162. Evers AW, Duller P, de Jong EM, Otero ME, Verhaak CM, van der Valk PG, van de Kerkhof PC, Kraaimaat FW. Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis. Acta Derm Venereol. 2009;89:57–63.

    Article  PubMed  Google Scholar 

  163. Bathe A, Matterne U, Dewald M, Grande T, Weisshaar E. Educational multidisciplinary training programme for patients with chronic pruritus. Acta Derm Venereol. 2009;89:498–501.

    Article  PubMed  Google Scholar 

  164. Rosenbaum MS, Ayllon T. The behavioral treatment of neurodermatitis through habit-reversal. Behav Res Ther. 1981;19:313–8.

    Article  CAS  PubMed  Google Scholar 

  165. Melin L, Frederiksen T, Noren P, Swebilius BG. Behavioural treatment of scratching in patients with atopic dermatitis. Br J Dermatol. 1986;115:467–74.

    Article  CAS  PubMed  Google Scholar 

  166. Norén P, Melin L. The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis. Br J Dermatol. 1989;121:359–66.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Venerology and Allergology, Wroclaw Medical University, Ul. Chalubinskiego 1, 50-368, Wroclaw, Poland

    Jacek C. Szepietowski MD & Radomir Reszke MD

Authors
  1. Jacek C. Szepietowski MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Radomir Reszke MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacek C. Szepietowski MD .

Editor information

Editors and Affiliations

  1. Centro Studi per la Ricerca Multidisciplinare e Rigenerativa Department of Dermatology, Università degli Studi Guglielmo Marconi, Rome, Italy

    Katlein França

  2. Department of Psychiatry, Central Michigan University College of Medicine, Saginaw, Michigan, USA

    Mohammad Jafferany

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Szepietowski, J.C., Reszke, R. (2017). Itch and Stress. In: França, K., Jafferany, M. (eds) Stress and Skin Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-46352-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-46352-0_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-46351-3

  • Online ISBN: 978-3-319-46352-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation